Making the impossible possible: Baby KJ and the road map to personalized gene-editing care

References

[1] Musunuru K, Grandinette SA, Wang X, et al. Patient-specific in vivo gene editing to treat a rare genetic disease. N Engl J Med. 2025; 392(22): 2235-2243.

[2] Nettesheim S, Kölker S, Karall D, et al. Incidence, disease onset and short-term outcome in urea cycle disorders—cross-border surveillance in Germany, Austria and Switzerland. Orphanet J Rare Dis. 2017; 12: 111.

[3] Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016; 533: 420-424.

[4] Kenjo E, Hozumi H, Makita Y, et al. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Nat Commun. 2021; 12(1): 7101

[5] Kassim SH, Urnov F, Musunuru K, et al. Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable. Nat Biotechnol. 2025; 43(7): 1047-1049.

[6] Kim J, Hu C, Moufawad El Achkar C, et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N Engl J Med. 2019; 381(17): 1644-1652.

[7] Lauffer MC, van Roon-Mom W, Aartsma-Rus A, et al. Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders. Commun Med (Lond). 2024; 4(1): 6.

[8] Adhikari AN, Gallagher RC, Wang Y, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020; 26(9): 1392-1397

[9] Wojcik MH, Zhang T, Ceyhan-Birsoy O, et al. Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project. Genet Med. 2021; 23(7): 1372-1375.

[10] Denton N, Mulberg AE, Molloy M, et al. Sharing is caring: a call for a new era of rare disease research and development. Orphanet J Rare Dis. 2022; 17(1): 389.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.